Group | Overall (n = 1935) | Female (n = 1578) | Male (n = 357) |
(i) 1-3 days | 367 (19.0%) | 286 (18.1%) | 81 (22.7%) |
(ii) 4-14 days | 949 (49.0%) | 790 (50.1%) | 159 (44.5%) |
(iii) chronic (15 days or more) | 563 (29.1%) | 451 (28.6%) | 112 (31.4%) |
n/a | 56 (2.9%) | 51 (3.2%) | 5 (1.4%) |
At least one preventative treatment | No prior preventative treatment | ||
overall | 904/1935 (46.7%) | 1031/1935 (53.3%) | |
(iv) ≥3 attacks | 672 (74.3%) | 627 (60.8%) | |
(v) <3 attacks | 209 (23.1%) | 371 (36.0%) | |
n/a | 23 (2.5%) | 33 (3.2%) |